Skip navigation

FDA issues emergency use authorization for remdesivir

Recently, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the investigational antiviral drug remdesivir for the treatment of hospitalized adults and children with COVID-19.

The FDA notes that while there is limited information about the effectiveness of remdesivir, the drug has demonstrated in a clinical trial to shorten the time to recovery in some patients.